1. Home
  2. APRE vs HWH Comparison

APRE vs HWH Comparison

Compare APRE & HWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • HWH
  • Stock Information
  • Founded
  • APRE 2006
  • HWH 2021
  • Country
  • APRE United States
  • HWH United States
  • Employees
  • APRE N/A
  • HWH N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • HWH Other Pharmaceuticals
  • Sector
  • APRE Health Care
  • HWH Health Care
  • Exchange
  • APRE Nasdaq
  • HWH Nasdaq
  • Market Cap
  • APRE 21.2M
  • HWH 21.2M
  • IPO Year
  • APRE 2019
  • HWH N/A
  • Fundamental
  • Price
  • APRE $2.62
  • HWH $0.29
  • Analyst Decision
  • APRE Strong Buy
  • HWH
  • Analyst Count
  • APRE 2
  • HWH 0
  • Target Price
  • APRE $15.50
  • HWH N/A
  • AVG Volume (30 Days)
  • APRE 35.9K
  • HWH 21.0M
  • Earning Date
  • APRE 03-25-2025
  • HWH 03-04-2025
  • Dividend Yield
  • APRE N/A
  • HWH N/A
  • EPS Growth
  • APRE N/A
  • HWH N/A
  • EPS
  • APRE N/A
  • HWH N/A
  • Revenue
  • APRE $1,310,839.00
  • HWH $1,174,367.00
  • Revenue This Year
  • APRE $134.21
  • HWH N/A
  • Revenue Next Year
  • APRE N/A
  • HWH N/A
  • P/E Ratio
  • APRE N/A
  • HWH N/A
  • Revenue Growth
  • APRE 130.31
  • HWH 44.55
  • 52 Week Low
  • APRE $2.15
  • HWH $0.25
  • 52 Week High
  • APRE $8.85
  • HWH $3.15
  • Technical
  • Relative Strength Index (RSI)
  • APRE 30.05
  • HWH 36.01
  • Support Level
  • APRE $2.59
  • HWH $0.25
  • Resistance Level
  • APRE $3.72
  • HWH $0.35
  • Average True Range (ATR)
  • APRE 0.35
  • HWH 0.04
  • MACD
  • APRE -0.13
  • HWH -0.00
  • Stochastic Oscillator
  • APRE 1.41
  • HWH 16.46

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About HWH HWH International Inc.

HWH International Inc is a purpose-driven lifestyle company enabling home-based people in the new GIG economy to create lasting wealth. Developing new pathways in the aid of helping people in their pursuit of Health, Wealth and Happiness.

Share on Social Networks: